- Email: [email protected]
Chemokine Receptor CCR9 is Associated With Poor Clinicopathologic Features in Patients With Gastric Adenocarcinoma
342
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
58.13. Thyroid Lobectomy for Indeterminate FNA: Not Without Consequence. C. J. Balentine,1,2 R. P. Domingo,3 R. Patel,3 J. W. Suliburk2; 1Houston VA Health Services Research & Development Center of Excellence, Houston, TX; 2 Michael E. DeBakey Department of Surgery, Houston, TX; 3 Department of Pathology At Baylor College of Medicine, Houston, TX 58.14. Molecular Regulation of Immunoproteasome Overexpression in Papillary Thyroid Carcinoma. X. Zhang, Q. Du, W. Gao, M. T. Stang; University of Pittsburgh Department of Surgery, Pittsburgh, PA 58.15. Notch1 Intracellular Domain Regulates Cell Proliferation and Migration in Well-differentiated Thyroid Carcinoma. X. Yu, R. Jaskula-Sztul, M. Kunnimalaiyaan, H. Chen; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 58.16. Nampt Expression is Upregulated in Well-differentiated Thyroid Carcinoma. X. Li,1,3 R. Shackelford,2 E. Kandil1; 1Tulane University Department of Surgery, New Orleans, LA; 2Tulane University Departement of Pathology, New Orleans, LA; 3Department of General Surgery, Xiangya Hospital, Changsha, Hunan 58.17. Modern-Day Presentation of Primary Hyperparathyroidism. S. E. Murray, P. Pathak, S. Schaefer, D. F. Schneider, H. Chen, R. S. Sippel; University of Wisconsin - Madison Department of Surgery, Madison, WI 58.18. Risk of Underlying Malignancy in Adrenal Incidentalomas. B. J. Allan,1 C. M. Thorson,1 R. M. Van Haren,1 P. Parikh,1 M. B. Albuja-Cruz,2 J. I. Lew1; 1University of Miami Leonard M. Miller School of Medicine, Miami, Florida; 2University of Colorado School of Medicine, Aurora, CO 58.19. Thyroid Follicular Neoplasms in the Elderly: Does the Risk of Malignancy Justify Thyroidectomy? H. M. Yong, T. W. Yen, B. Hunt, S. D. Wilson, D. B. Evans, T. S. Wang; Medical College of Wisconsin, Milwaukee, WI 58.20. Markedly Elevated Thyroglobulin Levels in the Pre-operative Thyroidectomy Patient Predict Cancer and Metastatic Burden. S. C. Oltmann, D. F. Schneider, H. Chen, R. S. Sippel; University of Wisconsin - Madison Department of Surgery, Madison, WI
ONCOLOGY 6: GENERAL ONCOLOGY 59.1. The General Surgeon’s Quandary: Atypical Lipomatous Neoplasm Versus Lipoma. S. B. Fisher,1 K. J. Baxter,1 D. Monson,2 D. R. Murray,1 S. Oskouei,2 S. W. Weiss,3 C. A. Staley,1 D. A. Kooby,1 S. K. Maithel,1 K. A. Delman1; 1 Department of Surgery, Division of Surgical Oncology, Atlanta, GA; 2Department of Orthopedic Surgery, Atlanta, GA; 3Department of Pathology, Atlanta, GA 59.2. Gender Disparities in Patient Referral for Malignant Pleural Effusions. C. Burke,2 L. Zhao,1 M. B. Orringer,1 A. C. Chang,1 J. Lin,1 R. M. Reddy1; 1University of Michigan Medical Center, Ann Arbor, MI; 2University of Washington, Seattle, WA
59.3. Predictors of Local Recurrence Following Surgery for Desmoid Tumors: Biology Trumps Technique. L. J. McGhan, I. T. Ma, B. A. Pockaj, R. J. Gray, N. Wasif; Mayo Clinic In Arizona, Phoenix, AZ
59.4. Cytogenetic Analysis in the Diagnosis and Management of Lipoblastomas: Results From a Single-Institution. S. C. Fallon,1 M. L. Brandt,1 J. R. Rodriguez,1 S. A. Vasudevan,1 M. E. Lopez,1 J. Hicks,2 E. S. Kim1; 1Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, Houston, TX; 2Department of Pathology, Texas Children’s Hospital and Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX
59.5. Common Patterns of Reconstruction for Mohs Defects in the Head and Neck. A. Ibrahim, A. Tobias, B. Lee, S. Lin; Beth Israel Deaconess Medical Center - Harvard Medical School, Boston, MA
59.6. Is Routine Lymphoscintigraphy Required for Cutaneous Melanoma Arising on the Extremity? T. L. Fitzgerald, E. M. Gronet, E. E. Zervos, J. H. Wong; East Carolina University Brody School of Medicine, Greenville, NC
59.7. Surgical Management of Ultra-Thick Melanomas. A. M. Blakely,1 J. S. Carniello,2 M. Barsky,3 M. P. Vezeridis,1 T. J. Miner1; 1Rhode Island Hospital/Alpert Medical School of Brown University, Providence, RI; 2Memorial Sloan-Kettering Cancer Center, New York, NY; 3Brown Alpert Medical School, Providence, RI
59.8. Chemokine Receptor CCR9 is Associated With Poor Clinicopathologic Features in Patients With Gastric Adenocarcinoma. A. K. Arrington, M. E. Ko, W. Lee, E. L. Heinrich, R. Nelson, J. Kim; City of Hope National Medical Center, Duarte, CA
59.9. Evaluating the Prognostic Value of Extensive Lymph Node Examinations in Gastric Adenocarcinoma: An Analysis of The Surveillance, Epidemiology, and End Results (SEER) Database. S. N. Jayarajan,1 S. Taghavi,1 A. Davey,3 B. Powers,1 A. Willis2; 1Temple University Hospital, Philadelphia, PA; 2Temple University School of Medicine, Philadelphia, PA; 3Temple University School of Public Health, Philadelphia, PA
59.10. Outcomes Following Splenectomy in Patients With Myeloid Neoplasms. K. L. Rialon,1 S. Thomas,1 E. P. Ceppa,2 S. N. Vaslef,1 D. S. Tyler,1 D. G. Blazer1; 1Duke University Medical Center, Durham, NC; 2Indiana University School of Medicine, Indianapolis, IN
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
58.13. Thyroid Lobectomy for Indeterminate FNA: Not Without Consequence. C. J. Balentine,1,2 R. P. Domingo,3 R. Patel,3 J. W. Suliburk2; 1Houston VA Health Services Research & Development Center of Excellence, Houston, TX; 2 Michael E. DeBakey Department of Surgery, Houston, TX; 3 Department of Pathology At Baylor College of Medicine, Houston, TX 58.14. Molecular Regulation of Immunoproteasome Overexpression in Papillary Thyroid Carcinoma. X. Zhang, Q. Du, W. Gao, M. T. Stang; University of Pittsburgh Department of Surgery, Pittsburgh, PA 58.15. Notch1 Intracellular Domain Regulates Cell Proliferation and Migration in Well-differentiated Thyroid Carcinoma. X. Yu, R. Jaskula-Sztul, M. Kunnimalaiyaan, H. Chen; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 58.16. Nampt Expression is Upregulated in Well-differentiated Thyroid Carcinoma. X. Li,1,3 R. Shackelford,2 E. Kandil1; 1Tulane University Department of Surgery, New Orleans, LA; 2Tulane University Departement of Pathology, New Orleans, LA; 3Department of General Surgery, Xiangya Hospital, Changsha, Hunan 58.17. Modern-Day Presentation of Primary Hyperparathyroidism. S. E. Murray, P. Pathak, S. Schaefer, D. F. Schneider, H. Chen, R. S. Sippel; University of Wisconsin - Madison Department of Surgery, Madison, WI 58.18. Risk of Underlying Malignancy in Adrenal Incidentalomas. B. J. Allan,1 C. M. Thorson,1 R. M. Van Haren,1 P. Parikh,1 M. B. Albuja-Cruz,2 J. I. Lew1; 1University of Miami Leonard M. Miller School of Medicine, Miami, Florida; 2University of Colorado School of Medicine, Aurora, CO 58.19. Thyroid Follicular Neoplasms in the Elderly: Does the Risk of Malignancy Justify Thyroidectomy? H. M. Yong, T. W. Yen, B. Hunt, S. D. Wilson, D. B. Evans, T. S. Wang; Medical College of Wisconsin, Milwaukee, WI 58.20. Markedly Elevated Thyroglobulin Levels in the Pre-operative Thyroidectomy Patient Predict Cancer and Metastatic Burden. S. C. Oltmann, D. F. Schneider, H. Chen, R. S. Sippel; University of Wisconsin - Madison Department of Surgery, Madison, WI
ONCOLOGY 6: GENERAL ONCOLOGY 59.1. The General Surgeon’s Quandary: Atypical Lipomatous Neoplasm Versus Lipoma. S. B. Fisher,1 K. J. Baxter,1 D. Monson,2 D. R. Murray,1 S. Oskouei,2 S. W. Weiss,3 C. A. Staley,1 D. A. Kooby,1 S. K. Maithel,1 K. A. Delman1; 1 Department of Surgery, Division of Surgical Oncology, Atlanta, GA; 2Department of Orthopedic Surgery, Atlanta, GA; 3Department of Pathology, Atlanta, GA 59.2. Gender Disparities in Patient Referral for Malignant Pleural Effusions. C. Burke,2 L. Zhao,1 M. B. Orringer,1 A. C. Chang,1 J. Lin,1 R. M. Reddy1; 1University of Michigan Medical Center, Ann Arbor, MI; 2University of Washington, Seattle, WA
59.3. Predictors of Local Recurrence Following Surgery for Desmoid Tumors: Biology Trumps Technique. L. J. McGhan, I. T. Ma, B. A. Pockaj, R. J. Gray, N. Wasif; Mayo Clinic In Arizona, Phoenix, AZ
59.4. Cytogenetic Analysis in the Diagnosis and Management of Lipoblastomas: Results From a Single-Institution. S. C. Fallon,1 M. L. Brandt,1 J. R. Rodriguez,1 S. A. Vasudevan,1 M. E. Lopez,1 J. Hicks,2 E. S. Kim1; 1Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, Houston, TX; 2Department of Pathology, Texas Children’s Hospital and Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX
59.5. Common Patterns of Reconstruction for Mohs Defects in the Head and Neck. A. Ibrahim, A. Tobias, B. Lee, S. Lin; Beth Israel Deaconess Medical Center - Harvard Medical School, Boston, MA
59.6. Is Routine Lymphoscintigraphy Required for Cutaneous Melanoma Arising on the Extremity? T. L. Fitzgerald, E. M. Gronet, E. E. Zervos, J. H. Wong; East Carolina University Brody School of Medicine, Greenville, NC
59.7. Surgical Management of Ultra-Thick Melanomas. A. M. Blakely,1 J. S. Carniello,2 M. Barsky,3 M. P. Vezeridis,1 T. J. Miner1; 1Rhode Island Hospital/Alpert Medical School of Brown University, Providence, RI; 2Memorial Sloan-Kettering Cancer Center, New York, NY; 3Brown Alpert Medical School, Providence, RI
59.8. Chemokine Receptor CCR9 is Associated With Poor Clinicopathologic Features in Patients With Gastric Adenocarcinoma. A. K. Arrington, M. E. Ko, W. Lee, E. L. Heinrich, R. Nelson, J. Kim; City of Hope National Medical Center, Duarte, CA
59.9. Evaluating the Prognostic Value of Extensive Lymph Node Examinations in Gastric Adenocarcinoma: An Analysis of The Surveillance, Epidemiology, and End Results (SEER) Database. S. N. Jayarajan,1 S. Taghavi,1 A. Davey,3 B. Powers,1 A. Willis2; 1Temple University Hospital, Philadelphia, PA; 2Temple University School of Medicine, Philadelphia, PA; 3Temple University School of Public Health, Philadelphia, PA
59.10. Outcomes Following Splenectomy in Patients With Myeloid Neoplasms. K. L. Rialon,1 S. Thomas,1 E. P. Ceppa,2 S. N. Vaslef,1 D. S. Tyler,1 D. G. Blazer1; 1Duke University Medical Center, Durham, NC; 2Indiana University School of Medicine, Indianapolis, IN